Cardiac computed tomography (CT) was initially developed as a non-invasive diagnostic
tool to detect and quantify coronary stenosis. Thanks to the rapid technological development,
cardiac CT has become a comprehensive imaging modality which offers anatomical and
functional information to guide patient management. This is the second of two complementary
documents endorsed by the European Association of Cardiovascular Imaging aiming to
give updated indications on the appropriate use of cardiac CT in different clinical
scenarios. In this article, emerging CT technologies and biomarkers, such as CT-derived
fractional flow reserve, perfusion imaging, and pericoronary adipose tissue attenuation,
are described. In addition, the role of cardiac CT in the evaluation of atherosclerotic
plaque, cardiomyopathies, structural heart disease, and congenital heart disease is
revised.